UB Paderborn / Katalog / Suche / in CDI

Potentially inappropriate medication in older psychiatric patients

European journal of clinical pharmacology, 2021-03, Vol.77 (3), p.331-339

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders

PloS one, 2021-07, Vol.16 (7), p.e0255192

2021

Link zum Volltext

Verfügbarkeit prüfen

Predicting the risk of drug–drug interactions in psychiatric hospitals: a retrospective longitudinal pharmacovigilance study

BMJ open, 2021-04, Vol.11 (4), p.e045276

2021

Link zum Volltext

Verfügbarkeit prüfen

Korrektur des Empfehlungsgrades für TDM

Nervenarzt, 2020, Vol.91 (1), p.75-76

2020

Link zum Volltext

Verfügbarkeit prüfen

Correction of the level of recommendation for TDM

Nervenarzt, 2020-01, Vol.91 (1), p.75-76

2020

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs—Influence of Smoking Behavior and Inflammation on Pharmacokinetics

Pharmaceuticals (Basel, Switzerland), 2021-05, Vol.14 (6), p.514

2021

Link zum Volltext

Verfügbarkeit prüfen

A novel blood-brain barrier co-culture system for drug targeting of Alzheimer's disease: establishment by using acitretin as a model drug

PloS one, 2014-03, Vol.9 (3), p.e91003

2014

Link zum Volltext

Verfügbarkeit prüfen

Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancy

Frontiers in psychiatry, 2022-10, Vol.13, p.972141-972141

2022

Link zum Volltext

Verfügbarkeit prüfen

The value of drug and metabolite concentration in blood as a biomarker of psychopharmacological therapy

International review of psychiatry (Abingdon, England), 2013-10, Vol.25 (5), p.494-508

2013

Link zum Volltext

Verfügbarkeit prüfen

Elevated Clozapine Blood Concentrations After Second COVID-19 Vaccination With Spikevax (COVID-19 Vaccine Moderna)

Journal of clinical psychopharmacology, 2022-05, Vol.42 (3), p.317

2022

Link zum Volltext

Verfügbarkeit prüfen

Off-label use of antidepressants, antipsychotics, and mood-stabilizers in psychiatry

Journal of Neural Transmission, 2022-11, Vol.129 (11), p.1353-1365

2022

Link zum Volltext

Verfügbarkeit prüfen

Polypharmacy and the risk of drug–drug interactions and potentially inappropriate medications in hospital psychiatry

Pharmacoepidemiology and drug safety, 2021-09, Vol.30 (9), p.1258-1268

2021

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and sort of pharmacokinetic drug–drug interactions in hospitalized psychiatric patients

Journal of Neural Transmission, 2020-08, Vol.127 (8), p.1185-1198

2020

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic Drug–Drug interactions of QT-prolonging drugs in hospitalized psychiatric patients

Journal of Neural Transmission, 2021-02, Vol.128 (2), p.243-252

2021

Link zum Volltext

Verfügbarkeit prüfen

Current use of anticholinergic medications in a large naturalistic sample of psychiatric patients

Journal of Neural Transmission, 2021-02, Vol.128 (2), p.263-272

2021

Link zum Volltext

Verfügbarkeit prüfen

Depression and cognitive deficits as long‐term consequences of thrombotic thrombocytopenic purpura

Transfusion (Philadelphia, Pa.), 2017-05, Vol.57 (5), p.1152-1162

2017

Link zum Volltext

Verfügbarkeit prüfen

Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels

Psychopharmacology, 2016-05, Vol.233 (9), p.1695-1705

2016

Link zum Volltext

Verfügbarkeit prüfen

Comedication of Valproic Acid Is Associated With Increased Metabolism of Clozapine

Journal of clinical psychopharmacology, 2018-06, Vol.38 (3), p.188-192

2018

Link zum Volltext

Verfügbarkeit prüfen

Severe adverse drug events under combination of nortriptyline and melperone due to pharmacokinetic interaction

Journal of clinical psychopharmacology, 2014-06, Vol.34 (3), p.394-396

2014

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic Drugs

Therapeutic drug monitoring, 2021-02, Vol.43 (1), p.79

2021

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic drug monitoring for patients with Alzheimer dementia to improve treatment with donepezil

Therapeutic drug monitoring, 2015-06, Vol.37 (3), p.353

2015

Link zum Volltext

Verfügbarkeit prüfen

Elevated risperidone serum concentrations during acute inflammation, two cases

International journal of psychiatry in medicine, 2015-10, Vol.50 (3), p.335

2015

Link zum Volltext

Verfügbarkeit prüfen

QTc Time Correlates with Amitriptyline and Venlafaxine Serum Levels in Elderly Psychiatric Inpatients

Pharmacopsychiatry, 2019-01, Vol.52 (1), p.38

2019

Link zum Volltext

Verfügbarkeit prüfen

TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians

The world journal of biological psychiatry, 2018-04, Vol.19 (3), p.162-174

2018

Link zum Volltext

Verfügbarkeit prüfen

Therapeutisches Drug-Monitoring in der Neuropsychopharmakologie: Zusammenfassung der Konsensusleitlinien 2017 der TDM-Arbeitsgruppe der AGNP

Nervenarzt, 2019-05, Vol.90 (5), p.463-471

2019

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Potentially inappropriate medication in older psychiatric patients

Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders

Predicting the risk of drug–drug interactions in psychiatric hospitals: a retrospective longitudinal pharmacovigilance study

Korrektur des Empfehlungsgrades für TDM

Correction of the level of recommendation for TDM

Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs—Influence of Smoking Behavior and Inflammation on Pharmacokinetics

A novel blood-brain barrier co-culture system for drug targeting of Alzheimer's disease: establishment by using acitretin as a model drug

Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancy

The value of drug and metabolite concentration in blood as a biomarker of psychopharmacological therapy

Elevated Clozapine Blood Concentrations After Second COVID-19 Vaccination With Spikevax (COVID-19 Vaccine Moderna)

Off-label use of antidepressants, antipsychotics, and mood-stabilizers in psychiatry

Polypharmacy and the risk of drug–drug interactions and potentially inappropriate medications in hospital psychiatry

Prevalence and sort of pharmacokinetic drug–drug interactions in hospitalized psychiatric patients

Pharmacodynamic Drug–Drug interactions of QT-prolonging drugs in hospitalized psychiatric patients

Current use of anticholinergic medications in a large naturalistic sample of psychiatric patients

Depression and cognitive deficits as long‐term consequences of thrombotic thrombocytopenic purpura

Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels

Comedication of Valproic Acid Is Associated With Increased Metabolism of Clozapine

Severe adverse drug events under combination of nortriptyline and melperone due to pharmacokinetic interaction

Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic Drugs

Therapeutic drug monitoring for patients with Alzheimer dementia to improve treatment with donepezil

Elevated risperidone serum concentrations during acute inflammation, two cases

QTc Time Correlates with Amitriptyline and Venlafaxine Serum Levels in Elderly Psychiatric Inpatients

TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians

Therapeutisches Drug-Monitoring in der Neuropsychopharmakologie: Zusammenfassung der Konsensusleitlinien 2017 der TDM-Arbeitsgruppe der AGNP

Suchergebnisse filtern